We accept all major credit cards and personal checks. Please feel free to contact our Customer Support Department for additional information.
The consents and HIPAA forms we received for previous testing are sufficient, however, we will need a new referral form. If you change fertility clinics, a new HIPAA form will be requested.
We do not work directly with insurance companies, however, your insurance company may be willing to reimburse you for the cost of your testing.
We can provide you with an itemized bill with the necessary information for insurance authorization. Diagnostic codes must be provided by your clinic, and we will provide all other required codes. If your test has not yet been performed, we can provide an itemized preliminary invoice.
If your insurance company will provide coverage for your test, we ask that you remit payment directly to IGENOMIX, and then request reimbursement from your insurance provider.
IGENOMIX specializes in overnight turnaround time for results for fresh transfer cases. Overnight turnaround time may not be available for every location and may not be appropriate for all patients. Your doctor will decide if a fresh or frozen transfer is best for you.
Yes, we can batch embryos from multiple stimulation cycles. This is a way to reduce the costs of testing when multiple stimulation cycles are planned. IGENOMIX accepts embryo samples from multiple cycles and performs testing for all embryos at once. The embryo biopsies can be sent separately at each cycle, or the clinic may store the biopsies. IGENOMIX can store them with no additional charge and can ensure optimal storage conditions. IGENOMIX will wait until the clinic notifies us that the last stimulation cycle is completed. At that time, IGENOMIX will perform the test for all embryo biopsies at the same time and will provide results as a single report. The costs incurred will be the same as for a single PGS test. There is no additional fee for batching of embryos, however, a shipping fee will apply each time samples are sent from the clinic. Payment is requested when the first set of embryos are sent to IGENOMIX. Ask your physician if batching is beneficial for you.
PGS testing involves two parts: (1) Biopsy performed by the clinic and (2) the genetic test performed by IGENOMIX. Your clinic will charge you for the biopsy, and IGENOMIX will charge for the test and any courier fees.
The embryo samples are sent to the lab that has optimal time and cost logistics. The protocols and procedures are the same in both labs, and both labs are of equal quality.
We will need a separate consent for each test performed by IGENOMIX. A single HIPAA form can be used for any testing with IGENOMIX.
Our financial team will charge you as soon as we get confirmation from your doctor that testing will take place. This is usually several days prior to embryo biopsy. However, if you change your mind, or the embryos don’t develop to where you can do the biopsy, we will refund your payment in full, with no cancellation fee.
You have done all the right steps so far. Prior to working with IGENOMIX, a mutation must be identified. This usually involves testing with another laboratory because IGENOMIX does not provide genetic test results for adults. IGENOMIX’s role is to test embryos for the mutation, and to do this, we have to build a probe. The probe is what we use to perform the genetic test on the embryos. When we test embryos, in addition to looking for the mutation, we also look for linked genetic markers. Our approach of looking for a combination of the mutation plus the markers increases the accuracy of the test. The markers themselves have no medical relevance, but they provide an additional way of tracking the mutation in the embryos. The purpose of obtaining blood samples for PGD is to help build the probe. Each couple will have a different set of markers that can be used. We need blood samples from both members of the couple to find the set of available markers. We also need DNA samples (blood or cheek swab) from family members to help determine which markers are linked to the mutation and which markers are linked to the normal copies of the gene.